North America Glucose Monitoring Market Forecast 2019-2027

North America Glucose Monitoring Market Forecast 2019-2027

KEY FINDINGS

The North America glucose monitoring system market accounted for the highest revenue share of the global market in 2018. Over the predicted years of 2019-2027, the CGMS market is expected to witness a CAGR of 31.03%, generating total revenue of $XX million. Meanwhile, the SMBG market is expected to grow at 4.69% CAGR while generating a total revenue of $XX million, by the end of the said forecast period.

MARKET INSIGHTS

Prevalence rates of diabetes in North America are in the range of XX% to XX% that is close to the top of the global scale. The U.S is the largest national diabetes market and Canada’s share in the global market is far greater than its population. Governments are strategizing several initiatives for the prevention of diabetes in the country and creating awareness among people with regular diabetes screenings, lifestyle counselling, and diabetes education, with no out of pocket costs. The diabetic products are also provided online and that too at discounted rates. The administrations are also making sure that all the individuals, especially in Canada, are covered for medically necessary physician and hospital series.

COMPETITIVE INSIGHTS

Becton Dickinson And Company, Roche Diagnostics, ARKRAY Inc., Johnson and Johnson, Wockhardt, Senseonics Inc., Terumo, I-Sens Inc., Abbott, Apex Biotechnology Corp., Dexcom, GlySens Inc., Nemaura Medical Inc., B Braun Melsungen AG, Insulet Corp., Morepen Laboratories Ltd., Medtronic, Ypsomed, Ascensia, and Tandem Diabetes Care are some of the leading companies in this region.